LLC xenografts were dissected after 14 days when tumor burden was mostly comparable between Flvcr1a;Cdh5-CreERT2 and control mice (Fig. S2), and the tumor vasculature was analyzed on histological sections following staining with the endothelial cell marker CD31 (Fig. 5B). The gene discussed is CDH5; the disease is neoplasm.